BridgeBio Pharma Inc

BBIO: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
zbLOCK|F@LOCK|^>Hvw$

Attruby's Momentum and an Advancing Pipeline Support BridgeBio's Long-Term Growth Outlook

Business Strategy and Outlook

BridgeBio Pharma is a biotechnology company focused on bridging the gap between genetic research and unmet patient needs. Its pipeline targets Mendelian disorders, precision oncology, and gene therapy, with four programs in late-stage development.

Sponsor Center